X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (865) 865
Conference Proceeding (21) 21
Book Review (18) 18
Publication (13) 13
Patent (5) 5
Book / eBook (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (557) 557
humans (538) 538
male (446) 446
female (408) 408
cardiac & cardiovascular systems (379) 379
middle aged (365) 365
aged (347) 347
abridged index medicus (240) 240
stents (226) 226
treatment outcome (161) 161
coronary angiography (152) 152
stent (130) 130
angioplasty (126) 126
angioplasty, balloon, coronary (117) 117
peripheral vascular disease (117) 117
restenosis (112) 112
risk factors (106) 106
hematology (104) 104
follow-up studies (98) 98
cardiovascular (96) 96
heart attacks (93) 93
mortality (88) 88
prospective studies (88) 88
care and treatment (86) 86
cardiology (85) 85
time factors (83) 83
cardiac patients (82) 82
adult (79) 79
thrombosis (79) 79
cardiology and cardiovascular medicine (78) 78
myocardial infarction - therapy (77) 77
coronary disease - therapy (75) 75
myocardial infarction (72) 72
coronary vessels (71) 71
animals (68) 68
heart attack (66) 66
coronary heart disease (63) 63
ticlopidine - analogs & derivatives (63) 63
prognosis (61) 61
analysis (60) 60
recurrence (60) 60
risk (59) 59
balloon angioplasty (55) 55
implantation (54) 54
platelet aggregation inhibitors - therapeutic use (54) 54
transluminal angioplasty (54) 54
electrocardiography (52) 52
clopidogrel (50) 50
percutaneous coronary intervention (50) 50
drug-eluting stents (49) 49
aged, 80 and over (47) 47
acute myocardial-infarction (46) 46
medicine, general & internal (46) 46
myocardial infarction - mortality (46) 46
coronary artery disease (44) 44
coronary restenosis - prevention & control (44) 44
internal medicine (44) 44
sirolimus - administration & dosage (44) 44
survival analysis (44) 44
abciximab (43) 43
genotype (43) 43
ticlopidine - therapeutic use (43) 43
drug therapy (42) 42
cardiovascular disease (41) 41
predictive value of tests (41) 41
multivariate analysis (40) 40
myocardial-infarction (39) 39
platelet aggregation inhibitors - administration & dosage (38) 38
risk assessment (38) 38
ticlopidine - administration & dosage (38) 38
antibodies, monoclonal - therapeutic use (36) 36
atherosclerosis (36) 36
heart (36) 36
immunoglobulin fab fragments - therapeutic use (36) 36
reperfusion (36) 36
diabetes (35) 35
double-blind method (35) 35
disease (34) 34
therapy (34) 34
coronary artery disease - therapy (33) 33
medicine & public health (33) 33
myocardial infarction - diagnostic imaging (33) 33
rats (33) 33
artery-disease (32) 32
coronary artery disease - mortality (32) 32
heart-disease (31) 31
placement (31) 31
coronary disease - diagnostic imaging (30) 30
expression (30) 30
myocardial infarction - physiopathology (30) 30
outcomes (30) 30
proportional hazards models (30) 30
randomized controlled trials as topic (30) 30
studies (30) 30
coronary-artery-disease (29) 29
polymorphism, genetic (29) 29
randomized-trial (29) 29
retrospective studies (28) 28
stents - adverse effects (28) 28
trial (28) 28
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 10, pp. 849 - 856
Objectives The aim of this prospective trial was to assess whether platelet reactivity to clopidogrel assessed with multiple electrode platelet aggregometry... 
Cardiovascular | Internal Medicine | clopidogrel | whole blood aggregometry | stent thrombosis | platelet aggregation | ADVERSE CARDIOVASCULAR EVENTS | PERCUTANEOUS CORONARY INTERVENTION | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | IMPLANTATION | PREDICTORS | RESISTANCE | BARE-METAL | ANTAGONISTS | AGGREGOMETRY | Prospective Studies | Platelet Function Tests - methods | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Thrombosis - epidemiology | Coronary Artery Disease - mortality | Electric Impedance | Ticlopidine - analogs & derivatives | Drug-Eluting Stents - adverse effects | Electrodes | Coronary Artery Disease - therapy | Point-of-Care Systems | Thrombosis - etiology | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Function Tests - instrumentation | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Coenzymes | Vasodilators | Adenosine diphosphate | Coronary heart disease | Thrombosis | Stent (Surgery) | Blood clot | Aggregation | Disease transmission | Blood platelets | Analysis | Adenosine triphosphatase | Drug therapy | Intervention | Anticoagulants | Aspirin | Heart attacks | Medical imaging | Cardiovascular disease | Studies | Confidence intervals | Coronary vessels | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9796, pp. 1071 - 1078
Journal Article
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 21, pp. 2383 - 2389
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 19, pp. 1760 - 1768
Objectives The aim of this trial was to compare the safety and efficacy of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) for treatment of... 
Cardiovascular | Internal Medicine | coronary artery disease | paclitaxel | restenosis | drug-eluting stents | left main coronary artery | sirolimus | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | METAANALYSIS | RANDOMIZED-TRIALS | BARE-METAL STENTS | PERCUTANEOUS INTERVENTION | SURGICAL REVASCULARIZATION | BYPASS GRAFT-SURGERY | IMPLANTATION | OUTCOMES | Confidence Intervals | Drug-Eluting Stents | Sirolimus - therapeutic use | Ticlopidine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Male | Risk | Coronary Artery Disease - drug therapy | Coronary Restenosis - drug therapy | Paclitaxel - therapeutic use | Coronary Restenosis - therapy | Ticlopidine - analogs & derivatives | Tubulin Modulators - therapeutic use | Angioplasty, Balloon, Coronary | Incidence | Coronary Angiography | Myocardial Infarction - therapy | Coronary Artery Disease - therapy | Myocardial Infarction - drug therapy | Female | Aged | Platelet Aggregation Inhibitors - therapeutic use | Transluminal angioplasty | Coronary artery bypass | Creatine kinase | Paclitaxel | Creatine | Cardiology | Coronary heart disease | Stent (Surgery) | Rapamycin | Intervention | Confidence intervals | Stroke | Heart attacks | Angioplasty | Heart surgery | Coronary vessels | Cardiovascular disease | Stents | Thrombosis | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 02/2010, Volume 121, Issue 4, pp. 512 - 518
Journal Article
Journal Article